TIME Journalist Steven Brill to Senators: PPACA Price Transparency Won’t Lower Costs

Steven Brill, JD, journalist and author of the incendiary Time article “Bitter Pill” that criticized hospital pricing practices, spoke before the Senate Finance Committee Tuesday, saying the Patient Protection and Affordable Care Act would not significantly lower prices for patients.

Advertisement

 

Mr. Brill sat on a panel at the committee’s hearing, joining Catalyst for Payment Reform Executive Director Suzanne Delbanco, PhD, Center for Studying Health System Change President Paul Ginsburg, PhD, and Castlight Health CEO and Co-Founder Giovanni Colella, MD.

 

Sens. Orrin Hatch (R-Utah) and Max Baucus (D-Mont.) agreed with Mr. Brill’s contention that although the law promotes much-needed transparency in healthcare prices, it does too little to push those prices down for consumers. “[Transparency] starts the conversation about prices that we didn’t have in the debate over Obamacare. It’s only a start,” Mr. Brill said. “Obamacare does nothing about these prices. Nothing to solve the problem. Zero.”

 

More Articles on Healthcare Reform:

GAO: Health Insurance Exchange Rollout Behind Schedule

Why Every Hospital Can’t Manage Population Health, and Why That’s OK

CEO Dereesa Reid: Continuing to Build at Hoag Orthopedic Institute

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.